Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

188.47
Delayed Data
As of Dec 08
 -1.26 / -0.66%
Today’s Change
184.50
Today|||52-Week Range
317.48
-39.69%
Year-to-Date
Should Biotech Investors Worry About Donald Trump?
Dec 08 / Zacks.com - Paid Partner Content
Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today
Dec 06 / Zacks.com - Paid Partner Content
Cramer: With Trump, Everything's a Negotiation
Dec 07 / TheStreet.com - Paid Partner Content
Questions Mount at Teva Amid C-suite Change
Dec 06 / TheStreet.com - Paid Partner Content
Trump Warns Investors "I'm Going To Bring Down Drug Prices"
Dec 07 / MotleyFool.com - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
Trump warns Wall Street: I'm going to cut drug prices
Dec 07 / CNNMoney.com
Week in Review, December 2
Dec 02 / FT.com - Paid Partner Content
Teva Copaxone EU Label to Omit Pregnancy Contraindication
Dec 07 / Zacks.com - Paid Partner Content
Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter
Dec 02 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close189.73
Today’s open188.93
Day’s range185.70 - 191.00
Volume7,569,122
Average volume (3 months)4,323,613
Market cap$71.2B
Dividend yield1.49%
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-0.05%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.04

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.23-0.65%
LLYEli Lilly and Co-0.19-0.28%
AZNAstraZeneca+0.42+1.62%
ABTAbbott Laboratories+0.20+0.52%
Data as of 12/08/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)$3.74
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs